H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 69 Citations 18,042 647 World Ranking 646 National Ranking 14
Medicine D-index 78 Citations 22,746 959 World Ranking 10750 National Ranking 106

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

The scientist’s investigation covers issues in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Leukemia. His Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Oncology. His biological study spans a wide range of topics, including CD34, Stem cell, Histocompatibility, Prospective cohort study and Acute leukemia.

His research in Hematopoietic stem cell transplantation intersects with topics in Bone marrow, Minimal residual disease and Antigen. In Immunology, Xiao-Jun Huang works on issues like Granulocyte colony-stimulating factor, which are connected to Immune tolerance. As a part of the same scientific study, Xiao-Jun Huang usually deals with the Leukemia, concentrating on Cancer research and frequently concerns with Metabolite.

His most cited work include:

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts (452 citations)
  • Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. (381 citations)
  • Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. (381 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Hematopoietic stem cell transplantation, Transplantation, Immunology and Gastroenterology. Xiao-Jun Huang has researched Internal medicine in several fields, including Surgery and Oncology. His Hematopoietic stem cell transplantation study incorporates themes from Acute leukemia, Chemotherapy and Minimal residual disease.

His work deals with themes such as Haematopoiesis, Stem cell, Human leukocyte antigen and Incidence, which intersect with Transplantation. The Gastroenterology study combines topics in areas such as Regimen, Cyclophosphamide, Retrospective cohort study, Platelet Engraftment and Risk factor. His Leukemia research incorporates elements of Myeloid and Cancer research.

He most often published in these fields:

  • Internal medicine (84.42%)
  • Hematopoietic stem cell transplantation (61.01%)
  • Transplantation (55.87%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (84.42%)
  • Hematopoietic stem cell transplantation (61.01%)
  • Transplantation (55.87%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Hematopoietic stem cell transplantation, Transplantation, Cumulative incidence and Gastroenterology are his primary areas of study. His study connects Oncology and Internal medicine. Xiao-Jun Huang works mostly in the field of Hematopoietic stem cell transplantation, limiting it down to topics relating to Acute leukemia and, in certain cases, Donor lymphocyte infusion, as a part of the same area of interest.

Xiao-Jun Huang combines subjects such as Haematopoiesis, Stem cell, Leukemia, Immunology and Human leukocyte antigen with his study of Transplantation. His study in Cumulative incidence is interdisciplinary in nature, drawing from both CEBPA, Hazard ratio, Confidence interval, Clinical endpoint and Cohort. Within one scientific family, Xiao-Jun Huang focuses on topics pertaining to Cyclophosphamide under Gastroenterology, and may sometimes address concerns connected to Regimen.

Between 2018 and 2021, his most popular works were:

  • Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3 (66 citations)
  • Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3 (66 citations)
  • The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation (38 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Xiao-Jun Huang mainly focuses on Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Cumulative incidence and Gastroenterology. Xiao-Jun Huang combines topics linked to Oncology with his work on Internal medicine. His studies in Transplantation integrate themes in fields like Leukemia, Minimal residual disease, Myeloid leukemia and Stem cell.

His Hematopoietic stem cell transplantation research incorporates themes from Donor selection, Prospective cohort study, Human leukocyte antigen and Granulocyte colony-stimulating factor. Xiao-Jun Huang interconnects Myeloid, Cytotoxic T cell, Clinical endpoint and Cohort in the investigation of issues within Cumulative incidence. His research integrates issues of Platelet Engraftment, Framingham Risk Score, Cyclophosphamide and Graft-versus-host disease in his study of Gastroenterology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Camille Abboud;Ellin Berman;Adam Cohen.
Blood (2013)

692 Citations

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

Dao-Pei Lu;Dao-Pei Lu;Lujia Dong;Lujia Dong;Tong Wu;Tong Wu;Xiao-Jun Huang;Xiao-Jun Huang.
Blood (2006)

586 Citations

Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

Huang Xj;Liu Dh;Liu Ky;Xu Lp.
Bone Marrow Transplantation (2006)

423 Citations

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.

Yu Wang;Qi-Fa Liu;Lan-Ping Xu;Kai-Yan Liu.
Blood (2015)

351 Citations

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

Xiao-Jun Huang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu.
Biology of Blood and Marrow Transplantation (2009)

349 Citations

Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Chen-Hua Yan;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu.
Blood (2012)

292 Citations

Who is the best donor for a related HLA haplotype-mismatched transplant?

Yu Wang;Ying-Jun Chang;Lan-Ping Xu;Kai-Yan Liu.
Blood (2014)

266 Citations

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Hong-Hu Zhu;Xiao-Hui Zhang;Ya-Zhen Qin;Dai-Hong Liu.
Blood (2013)

257 Citations

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center.

Yu Wang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu.
Cancer (2013)

256 Citations

CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL

Y Kong;S Yoshida;Y Saito;T Doi.
Leukemia (2008)

194 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Xiao-Jun Huang

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 93

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 83

Myriam Labopin

Myriam Labopin

Université Paris Cité

Publications: 64

Fabio Ciceri

Fabio Ciceri

Vita-Salute San Raffaele University

Publications: 54

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 51

Bipin N. Savani

Bipin N. Savani

Vanderbilt University Medical Center

Publications: 44

Øystein Bruserud

Øystein Bruserud

University of Bergen

Publications: 37

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 35

Andrea Bacigalupo

Andrea Bacigalupo

Catholic University of the Sacred Heart

Publications: 35

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 34

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 30

Gérard Socié

Gérard Socié

Université Paris Cité

Publications: 30

Elias Jabbour

Elias Jabbour

The University of Texas MD Anderson Cancer Center

Publications: 27

Jan Storek

Jan Storek

University of Calgary

Publications: 25

Jerald P. Radich

Jerald P. Radich

Fred Hutchinson Cancer Research Center

Publications: 25

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 24

Something went wrong. Please try again later.